6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide

C111H110Cl2F15N17O15 — CID 163826214

IUPAC6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide
SMILESCC(F)(F)OC1CC(c2nnc(C34CC(NC(=O)c5ccc6cc(C(F)(F)F)ccc6n5)(C3)C4)o2)C1.CC(F)(F)OC1CC(c2nnc(C34CC(NC(=O)c5ccc6cc(Cl)ccc6n5)(C3)C4)o2)C1.CC[C@@H]1C[C@H]1c1nnc(C23CC(NC(=O)COc4ccc(Cl)c(F)c4)(C2)C3)o1.Cc1ccc(-c2cn(C34CC(NC(=O)COC5CC(OC(F)(F)F)C5)(C3)C4)cn2)c(F)c1.Cc1ccc(-c2cn(C34CC(NC(=O)COC5CC(OC(F)(F)F)C5)(C3)C4)cn2)cc1
InChIInChI=1S/C24H21F5N4O3.C23H21ClF2N4O3.C22H23F4N3O3.C22H24F3N3O3.C20H21ClFN3O3/c1-21(25,26)36-15-7-13(8-15)19-32-33-20(35-19)22-9-23(10-22,11-22)31-18(34)17-4-2-12-6-14(24(27,28)29)3-5-16(12)30-17;1-21(25,26)33-15-7-13(8-15)19-29-30-20(32-19)22-9-23(10-22,11-22)28-18(31)17-4-2-12-6-14(24)3-5-16(12)27-17;1-13-2-3-16(17(23)4-13)18-7-29(12-27-18)21-9-20(10-21,11-21)28-19(30)8-31-14-5-15(6-14)32-22(24,25)26;1-14-2-4-15(5-3-14)18-8-28(13-26-18)21-10-20(11-21,12-21)27-19(29)9-30-16-6-17(7-16)31-22(23,24)25;1-2-11-5-13(11)17-24-25-18(28-17)19-8-20(9-19,10-19)23-16(26)7-27-12-3-4-14(21)15(22)6-12/h2-6,13,15H,7-11H2,1H3,(H,31,34);2-6,13,15H,7-11H2,1H3,(H,28,31);2-4,7,12,14-15H,5-6,8-11H2,1H3,(H,28,30);2-5,8,13,16-17H,6-7,9-12H2,1H3,(H,27,29);3-4,6,11,13H,2,5,7-10H2,1H3,(H,23,26)/t;;;;11-,13-,19?,20?/m....1/s1
InChIKeyNZSMNQRPIYVVLR-RNAUIHGNSA-N
MW2278.08 g/mol
LogP21.13
Rot. Bonds33

About 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide

6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide (PubChem CID 163826214) has the molecular formula C111H110Cl2F15N17O15 and a molecular weight of 2278.08 g/mol. Its IUPAC name is 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide.

Molecular Properties

Compound Name6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide
PubChem CID163826214
Molecular FormulaC111H110Cl2F15N17O15
Molecular Weight2278.08 g/mol
Exact Mass2275.75
IUPAC Name6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide
SMILESCC(F)(F)OC1CC(c2nnc(C34CC(NC(=O)c5ccc6cc(C(F)(F)F)ccc6n5)(C3)C4)o2)C1.CC(F)(F)OC1CC(c2nnc(C34CC(NC(=O)c5ccc6cc(Cl)ccc6n5)(C3)C4)o2)C1.CC[C@@H]1C[C@H]1c1nnc(C23CC(NC(=O)COc4ccc(Cl)c(F)c4)(C2)C3)o1.Cc1ccc(-c2cn(C34CC(NC(=O)COC5CC(OC(F)(F)F)C5)(C3)C4)cn2)c(F)c1.Cc1ccc(-c2cn(C34CC(NC(=O)COC5CC(OC(F)(F)F)C5)(C3)C4)cn2)cc1
InChIInChI=1S/C24H21F5N4O3.C23H21ClF2N4O3.C22H23F4N3O3.C22H24F3N3O3.C20H21ClFN3O3/c1-21(25,26)36-15-7-13(8-15)19-32-33-20(35-19)22-9-23(10-22,11-22)31-18(34)17-4-2-12-6-14(24(27,28)29)3-5-16(12)30-17;1-21(25,26)33-15-7-13(8-15)19-29-30-20(32-19)22-9-23(10-22,11-22)28-18(31)17-4-2-12-6-14(24)3-5-16(12)27-17;1-13-2-3-16(17(23)4-13)18-7-29(12-27-18)21-9-20(10-21,11-21)28-19(30)8-31-14-5-15(6-14)32-22(24,25)26;1-14-2-4-15(5-3-14)18-8-28(13-26-18)21-10-20(11-21,12-21)27-19(29)9-30-16-6-17(7-16)31-22(23,24)25;1-2-11-5-13(11)17-24-25-18(28-17)19-8-20(9-19,10-19)23-16(26)7-27-12-3-4-14(21)15(22)6-12/h2-6,13,15H,7-11H2,1H3,(H,31,34);2-6,13,15H,7-11H2,1H3,(H,28,31);2-4,7,12,14-15H,5-6,8-11H2,1H3,(H,28,30);2-5,8,13,16-17H,6-7,9-12H2,1H3,(H,27,29);3-4,6,11,13H,2,5,7-10H2,1H3,(H,23,26)/t;;;;11-,13-,19?,20?/m....1/s1
InChIKeyNZSMNQRPIYVVLR-RNAUIHGNSA-N
XLogP21.13
TPSA388.29 Ų
H-Bond Donors5
H-Bond Acceptors27
Rotatable Bonds33
Heavy Atoms160
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002278.08
LogP ≤ 521.13
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1027

Analyze 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide?
The IUPAC name of 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide (CID 163826214) is 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide.
What is the SMILES notation for 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide?
The canonical SMILES for 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide is CC(F)(F)OC1CC(c2nnc(C34CC(NC(=O)c5ccc6cc(C(F)(F)F)ccc6n5)(C3)C4)o2)C1.CC(F)(F)OC1CC(c2nnc(C34CC(NC(=O)c5ccc6cc(Cl)ccc6n5)(C3)C4)o2)C1.CC[C@@H]1C[C@H]1c1nnc(C23CC(NC(=O)COc4ccc(Cl)c(F)c4)(C2)C3)o1.Cc1ccc(-c2cn(C34CC(NC(=O)COC5CC(OC(F)(F)F)C5)(C3)C4)cn2)c(F)c1.Cc1ccc(-c2cn(C34CC(NC(=O)COC5CC(OC(F)(F)F)C5)(C3)C4)cn2)cc1.
What is the InChIKey of 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide?
The InChIKey is NZSMNQRPIYVVLR-RNAUIHGNSA-N. The full InChI is InChI=1S/C24H21F5N4O3.C23H21ClF2N4O3.C22H23F4N3O3.C22H24F3N3O3.C20H21ClFN3O3/c1-21(25,26)36-15-7-13(8-15)19-32-33-20(35-19)22-9-23(10-22,11-22)31-18(34)17-4-2-12-6-14(24(27,28)29)3-5-16(12)30-17;1-21(25,26)33-15-7-13(8-15)19-29-30-20(32-19)22-9-23(10-22,11-22)28-18(31)17-4-2-12-6-14(24)3-5-16(12)27-17;1-13-2-3-16(17(23)4-13)18-7-29(12-27-18)21-9-20(10-21,11-21)28-19(30)8-31-14-5-15(6-14)32-22(24,25)26;1-14-2-4-15(5-3-14)18-8-28(13-26-18)21-10-20(11-21,12-21)27-19(29)9-30-16-6-17(7-16)31-22(23,24)25;1-2-11-5-13(11)17-24-25-18(28-17)19-8-20(9-19,10-19)23-16(26)7-27-12-3-4-14(21)15(22)6-12/h2-6,13,15H,7-11H2,1H3,(H,31,34);2-6,13,15H,7-11H2,1H3,(H,28,31);2-4,7,12,14-15H,5-6,8-11H2,1H3,(H,28,30);2-5,8,13,16-17H,6-7,9-12H2,1H3,(H,27,29);3-4,6,11,13H,2,5,7-10H2,1H3,(H,23,26)/t;;;;11-,13-,19?,20?/m....1/s1.
What are the key properties of 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide?
6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide has a molecular weight of 2278.08 g/mol, XLogP of 21.13, 33 rotatable bonds, 5 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 6-chloro-N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]quinoline-2-carboxamide;2-(4-chloro-3-fluorophenoxy)-N-[3-[5-[(1R,2R)-2-ethylcyclopropyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide;N-[3-[5-[3-(1,1-difluoroethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]-6-(trifluoromethyl)quinoline-2-carboxamide;N-[3-[4-(2-fluoro-4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide;N-[3-[4-(4-methylphenyl)imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]-2-[3-(trifluoromethoxy)cyclobutyl]oxyacetamide is sourced from PubChem (CID 163826214), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).